ETNB
89bio, Inc.Company Information
- Company Name
- 89bio, Inc.
- CIK
- CIK0001785173
- Category
- Large accelerated filer
- Ticker: Exchange
- ETNB: None
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ETNB
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-01-30
- Last sale
- 2025-07-15
- Shares purchased (TTM)
- 5,749,285
- Shares sold (TTM)
- 64,708
Institutional Sentiment
- As of
- 2025-09-30
- Institutional shares owned
- 145,915,377
- Shares outstanding
- 157,880,203
- Ownership
- 92.42%
Earnings Market Reaction
- Filing date
- —
- Price on filing date
- —
- 1-month reaction
- —
- 3-month reaction
- —
Balance Sheet
Values in millions ($)| Line item | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 129 | 315 | 126 | 91 | 212 | 218 | 316 | 252 | 245 | 351 | 55 | 72 | ||||||
| Marketable Securities Current | 432 | 323 | 314 | 332 | 319 | 345 | 263 | - | - | - | 133 | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 602 | 683 | 476 | 456 | 580 | 575 | 594 | 460 | 492 | 494 | 196 | 200 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Prepaid Expense And Other Assets Current | 40 | 44 | 36 | 32 | 48 | 12 | 15 | 11 | 14 | 13 | 8 | 7 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 603 | 685 | 479 | 458 | 582 | 577 | 596 | 460 | 493 | 494 | 197 | 201 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 15 | 15 | 15 | 19 | 17 | 15 | 9 | 11 | 11 | 17 | 13 | 14 | ||||||
Liabilities Current | ||||||||||||||||||
| Accrued Liabilities Current | 24 | 22 | 20 | 19 | 19 | 20 | 21 | 14 | 15 | 7 | 12 | 13 | ||||||
| Liabilities Current | 40 | 38 | 36 | 39 | 42 | 38 | 30 | 25 | 26 | 24 | 25 | 34 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Debt Current | - | - | - | - | 5 | 2 | - | - | - | - | - | 7 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | ||||||
| Derivative Liabilities Noncurrent | 0 | 0 | 1 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Long Term Debt Noncurrent | 36 | 36 | 36 | 36 | 20 | 23 | 25 | 25 | 24 | 24 | 20 | 13 | ||||||
| Other Liabilities Noncurrent | 5 | 5 | 4 | 4 | 4 | 4 | 4 | - | - | - | - | - | ||||||
| Liabilities | 82 | 80 | 78 | 80 | 67 | 67 | 60 | 50 | 51 | 48 | 45 | 48 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,529 | 1,501 | 1,225 | 1,083 | 1,073 | 1,020 | 993 | 828 | 825 | 790 | 467 | 444 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 1 | 1 | -1 | -1 | 0 | -1 | -1 | -0 | -0 | -0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 522 | 605 | 401 | 378 | 515 | 511 | 536 | 410 | 442 | 446 | 152 | 153 | ||||||
| Retained Earnings Accumulated Deficit | -1,007 | -896 | -825 | -706 | -557 | -509 | -457 | -417 | -382 | -344 | -315 | -291 | ||||||
| Liabilities And Stockholders Equity | 603 | 685 | 479 | 458 | 582 | 577 | 596 | 460 | 493 | 494 | 197 | 201 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | - | - | - | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | - | - | 10 | - | - | - | 10 | - | - | - | 10 | - | ||||||
| Preferred Stock Shares Issued | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 0.00 | - | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | - | - | - | 100 | - | ||||||
| Common Stock Shares Issued | 148 | 146 | 120 | 106 | 105 | 95 | 93 | - | - | - | 51 | - | ||||||
| Shares Outstanding | 148 | 146 | 120 | 106 | 105 | 95 | 93 | - | - | - | 51 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trial89bio, Inc. (ETNB) — SEC Financial Statements & Analysis
89bio, Inc. (ETNB) is a pharmaceutical preparations company, incorporated in DE. 89bio, Inc. trades on None as: ETNB. 89bio, Inc. (ETNB)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-08. Based on that filing, On profitability, 89bio, Inc. posts a Return on Equity (ROE) of -86.86%, a Return on Assets (ROA) of -75.94%, and a Return on Invested Capital (ROIC) of -122.72%. Per share, it reports EPS of $-2.85, diluted EPS of $-2.85, free cash flow per share of $-2.78, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 157.83% year-over-year and EPS growth of 63.03% year-over-year. On the balance sheet, it maintains a current ratio of 15.19x, a quick ratio of 14.17x, working capital of $561.91M, a debt-to-equity ratio of 0.16x, a debt ratio of 0.14, an interest coverage ratio of -78.17x, free cash flow of $-439.17M (TTM), and net debt of $-92.92M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-2.85
- ROE TTM
- -86.86%
- ROA TTM
- -75.94%
- Debt To Equity
- 0.16x
- Free Cash Flow TTM
- $-439.17M
Data as of 2025-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is 89bio, Inc. in?
89bio, Inc. (ETNB) operates in the Pharmaceutical Preparations industry.
What exchange does ETNB trade on?
89bio, Inc. (ETNB) trades on the None.
Where is 89bio, Inc. incorporated?
89bio, Inc. is incorporated in DE.
When was 89bio, Inc. (ETNB)'s most recent SEC filing?
89bio, Inc. (ETNB)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-08.
What is ETNB's EPS (earnings per share)?
89bio, Inc. (ETNB)'s trailing twelve month EPS is $-2.85 as of 2025-06-30.
What is ETNB's ROE (return on equity)?
89bio, Inc. (ETNB)'s trailing twelve month Return on Equity (ROE) is -86.86% as of 2025-06-30.
What is ETNB's ROA (return on assets)?
89bio, Inc. (ETNB)'s trailing twelve month Return on Assets (ROA) is -75.94% as of 2025-06-30.
What is ETNB's ROIC (return on invested capital)?
89bio, Inc. (ETNB)'s trailing twelve month Return on Invested Capital (ROIC) is -122.72% as of 2025-06-30.